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Abstract
Inorganic arsenic is a worldwide metalloid pollutant in environment. Although extensive studies on arsenic-induced toxicity
have been conducted using in vivo and in vitro models, the exact molecular mechanism of arsenate toxicity remains elusive.
Here, the RNA-SAGE (serial analysis of gene expression) sequencing technology was used to analyse hepatic response to
arsenic exposure at the transcriptome level. Based on more than 12 million SAGE tags mapped to zebrafish genes, 1,444
differentially expressed genes (750 up-regulated and 694 down-regulated) were identified from a relatively abundant
transcripts (.10 TPM [transcripts per million]) based on minimal two-fold change. By gene ontology analyses, these
differentially expressed genes were significantly enriched in several major biological processes including oxidation
reduction, translation, iron ion transport, cell redox, homeostasis, etc. Accordingly, the main pathways disturbed include
metabolic pathways, proteasome, oxidative phosphorylation, cancer, etc. Ingenity Pathway Analysis further revealed a
network with four important upstream factors or hub genes, including Jun, Kras, APoE and Nr2f2. The network indicated
apparent molecular events involved in oxidative stress, carcinogenesis, and metabolism. In order to identify potential
biomarker genes for arsenic exposure, 27 out of 29 up-regulated transcripts were validated by RT-qPCR analysis in pooled
RNA samples. Among these, 14 transcripts were further confirmed for up-regulation by a lower dosage of arsenic in majority
of individual zebrafish. Finally, at least four of these genes, frh3 (ferrintin H3), mgst1 (microsomal glutathione S-transferase-
like), cmbl (carboxymethylenebutenolidase homolog) and slc40a1 (solute carrier family 40 [iron-regulated transporter],
member 1) could be confirmed in individual medaka fish similarly treated by arsenic; thus, these four genes might be robust
arsenic biomarkers across species. Thus, our work represents the first comprehensive investigation of molecular mechanism
of asenic toxicity and genome-wide search for potential biomarkers for arsenic exposure.
Citation: Xu H, Lam SH, Shen Y, Gong Z (2013) Genome-Wide Identification of Molecular Pathways and Biomarkers in Response to Arsenic Exposure in Zebrafish
Liver. PLoS ONE 8(7): e68737. doi:10.1371/journal.pone.0068737
Editor: Xiaoping Pan, East Carolina University, United States of America
Received February 26, 2013; Accepted May 31, 2013; Published July 29, 2013
Copyright:  2013 Xu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research
Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no
role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.
Competing Interests: The authors have read the journal’s policy and have the following conflict: Zhiyuan Gong is an Academic Editor of PLoS ONE. This does
not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. All other authors declare that no competing interests exist.
* E-mail: dbsgzy@nus.edu.sg
Introduction
Arsenic is a worldwide and mobile metalloid pollutant in
environment. In nature, arsenic sulfides is converted to arsenic
trioxide with rock weathering and enters into the arsenic cycle
either as dust or by dissolution in rain, rivers or groundwater [1–
3]. The majority of arsenic entering the organisms is in the
pentavalent inorganic form As(V) via a simple diffusion mecha-
nism [4] and is immediately reduced to trivalent arsenic As(III).
Then organic and inorganic forms of arsenic are expelled in urine
after several days, although some remain in the body for months
or even longer [5,6]. It is widely accepted that chronic exposure to
inorganic arsenic can cause various diseases including cancers in
skin, bladder, liver, kidney and lung [7,8], diabetes [9], skin lesions
(dyspigmentation, keratosis), peripheral vascular diseases, as well
as disorders in the reproduction and nervous systems [10–12].
Numerous studies have been conducted to demonstrate the
cellular and molecular mechanisms underlying the arsenic-
induced pathology in human, indicating the association of
environmental arsenic exposure with the development of diseases
[1,12–14].
However, although the data from some laboratory studies
support the incidence and clinical symptoms of arsenic-induced
diseases, available experimental data are insufficient to explain the
epidemiological findings because of the limitation of technology
and experimental models so far used [15]. To understand the
clinical syndromes of arsenic-caused human diseases, it is
important to use in vivo animal models. The zebrafish (Danio
rerio) has become a popular vertebrate model system in toxicology
and human disease studies because of its several inherent features:
ease of obtaining a large number of animals for a statistical
advantage, low animal husbandry cost for large-scale studies, and
well established genetic and genomic tools including the availabil-
ity of the complete genome sequence. Furthermore, genomic
studies have proven that zebrafish and human generally share a
common set of genes with well conserved gene synteny [16–19]
and many important genes in development and molecular
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pathways including carcinogenesis are highly conserved and
similarly regulated between zebrafish and human [20,21].
Previously, our group has used a spotted DNA microarray
platform, which included less than half of zebrafish genes in the
genome, to analyse molecular response to arsenic exposure in
zebrafish and provided preliminary evidence that arsenic can
aberrantly regulate a series of genes associated with arsenic
metabolism and oxidation, leading to DNA and protein damage,
and thus cellular injury [22]. Now with the recently developed
RNA sequencing technology, it is feasible to carry out genome-
wide investigation of transcriptomic changes to toxicant insults as
RNA sequencing is capable of measuring transcript abundance
without the limitations of the predefined array content [23–25].
Furthermore, this analysis will not only help identify new
biomarker genes for arsenic exposure but also allow us to analyse
arsenic-altered biological pathways and potentially associated
disease status. Currently there is no report for using the RNA
sequencing platform to analyse transcriptomic response to arsenic
exposure from either in vitro or in vivo models. In the present
study, we employed the RNA sequencing platform to re-examine
the molecular response of zebrafish liver to arsenic exposure and
carry out detailed transcriptomic analyses for further understand-
ing of molecular toxicity. We found that several important
biological processes were perturbed by arsenic exposure, including
oxidation reduction, translation, iron ion transport, cell redox and
homeostasis, as well as related pathways in metabolism and
diseases. Furthermore, as there are currently no biomarker genes
available for predicting arsenic exposure, we took the advantage of
RNA sequencing platform to identify most suitable biomarker
genes from top responsive genes to arsenic exposure. We first
validated these top responsive genes by RT-qPCR in zebrafish and
then in Japanese medaka (Oryzias latipes) at individual fish level for
more robustly responsive genes across different fish species.
Materials and Methods
Fish
Adult zebrafish (3-month old) were purchased from a local
aquarium farm (Mainland Tropical Fish Farm, Singapore) and
acclimated for at least one week in the departmental aquarium
prior to chemical treatments. Medaka fish were bred in house and
3-month-old adult fish were used in the experiment. Experimental
procedures were carried out following the approved protocol by
Institutional Animal Care and Use Committee of National
University of Singapore (Protocol 079/07).
Chemical Exposure
As(V) or sodium arsenate (Na2HAsO4N7H2O) was purchased
from Sigma-Aldrich (USA) and dissolved in water. As previously
reported, LC50 of 96 h arsenic treatment in adult zebrafish was
estimated to be within 20–25 ppm sodium arsenate [22]. In this
study, we first used a relative high concentration (20 ppm) of
sodium arsenate to treat zebrafish for RNA sequencing in order to
ensure a toxicological response. Then we used a slight lower
concentration (15 ppm) for more robust validation of arsenic
responsive genes in zebrafish. For validation of biomarker genes in
medaka, 20 ppm sodium arsenate was used as medaka were more
tolerant to toxicant treatment based on our experience. For all
treatment experiments, static exposure was conducted for only
male fish at ambient temperature (28uC). The water and sodium
arsenate were replaced daily and the fish were not fed throughout
the 96-hour treatment.
RNA Sample Preparation for SAGE Library Sequencing
Treated and untreated control fish were sacrificed and livers
were collected from each fish. Total RNA was extracted using
Trizol Reagent (Invitrogen). SAGE (series analysis of gene
expression) RNA sequencing was carried out by Mission Biotech
(Taiwan) using SOLiDTM Analyzer 4 (Applied Biosystems).
Briefly, poly A RNA was purified using DynabeadsH Oligo(dT)
EcoP (Invitrogen) and subjected to cDNA synthesis. Synthesized
cDNA was digested by NlaIII and sequencing adapters were
ligated to the cDNA fragments. All SAGE tags were mapped to
the zebrafish Reference Sequence database (http://www.ncbi.
nlm.nih.gov/RefSeq/) with allowance of maximum 2 mismatches
and mapped tags for each transcript were normalized to TPM (tag
counts per million). Only tags with unambiguous mapping to a
single gene ID were considered in subsequent analyses.
Differentially Expressed Genes and Gene Ontology
Analysis
To analyse physiologically important genes, we selected
transcripts with TPM.10 in at least one group of samples
(control or treated) to be included for subsequent bioinformatic
analyses. As it is impossible to get p-values from single samples,
here we used fold-change (.2) to select differentially expressed
genes, as previous studies showed that the actually measured
magnitude of differential expression (fold change or ratio) is more
consistent and reproducible in identifying differentially expressed
genes than the statistical significance (p-value) [26,27]. For
calculation of fold changes, when a gene transcript was zero in
one set of data, we assumed one SAGE tag was observed for the
transcript and it was converted to p.2 TPM for a total of 0.2 TPM
for a total of ,5 million mapped tags in each sample. For the
differentially expressed gene set, gene ontology (GO) analysis was
conducted using DAVID (The Database for Annotation, Visual-
ization and Integrated Discovery) [28] with the total zebrafish
genome information as the background. Gene Ontology Fat
categories were used for this analysis with a p-value cut-off of 0.05.
Ingenuity Pathway Analysis (IPA)
To infer diseases and upstream factors associated with arsenic
perturbation, IPA (Ingenuity Pathway Analysis) software (www.
ingenuity.com) was used to analyse differentially expressed genes.
Each gene identifier was mapped to its corresponding human
homolog in the Ingenuity Pathways Knowledge Base. Out of the
1,444 differentially expressed genes, 1,025 genes were mapped to
921 human homologs and 707 genes were assigned to biological
function analysis in the IPA database. For human homologs
mapped with multiple zebrafish genes, the highest fold changes of
zebrafish genes were used for subsequent functional implication
analyses.
Comparative Toxicogenomic Dataset (CTD) Analysis
The differentially expressed genes were further compared with
CTD-curated genes/proteins that interact with arsenate (http://
ctdbase.org/) [29,30]. The CTD Batch Query tool was first used
to retrieve all curated chemical-gene interactions for the term
‘‘sodium arsenate’’ and 1,129 genes were then retrieved in the
dataset CTD_C009277_genes. MyGeneVenn was used to analyse
the intersection between our differential expressed gene set and the
CTD_C009277_genes. Enriched pathways were identified by
Gene Set Enricher available from CTD website http://ctdbase.
org/tools/enricher.go).
Transcriptomic Analyses of Arsenic Exposure
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RT-qPCR
Total RNA was extracted from livers of arsenic-treated and
untreated zebrafish or medaka. 2 mg of DNase-treated total RNA
was used for synthesizing first strand cDNA using an oligo-dT
primer and SuperScriptTMII Reverse Transcriptase according to
the manufacturer’s protocol (Invitrogen). The cDNA samples were
used for qPCR analysis using Lightcycler-FastStart DNA Master
SYBR Green 1 and Lightcycler480 (Roche Applied Science)
according to the manufacturer’s instruction. In our unpublished
experiments, seven housekeeping genes (rnf7, rplp2, rppl13a, rplp0,
b-actin1, hrp1 and b2m) were compared as internal control under
different chemical treatment conditions and the geometric mean of
three genes (rnf7, rplp2 and rppl13a) was used as the normalized
factor since it was evaluated as the best internal control by the the
software GeNorm Plus [31–33]. The 2DDCt represents the
expression level of genes, the statistical comparison of the relative
mean expression level for each gene between test and control
groups was performed using Student’s T-test with P-value,0.05
being considered significant. The cluster figure was generated by
software Mev4.
Results
Gene Ontology Analysis of Differentially Expressed Genes
Caused by Arsenic Exposure
Totally, 27.2 million SAGE tags, 13.6 million each from
arsenic-treated and untreated control samples, were obtained from
RNA sequencing. After mapping to the zebrafish Reference
Sequence database, 5.6 million and 6.9 million uniquely mapped
tags were mapped to 8,318 and 8,434 gene entries, respectively,
from the arsenic-treated and untreated groups. The RNA-seq data
were submitted to Gene Expression Omnibus with an access
number GSE48427). The distribution of tag entities and total tag
counts over different tag abundance categories are shown in
Figure 1A and the arsenic-treated and untreated groups had very
similar profiles. The abundance of transcripts from the two groups
ranged from 0.2 to 130,132 TPM in abundance. In general, a low
percentage of gene entries have a high TPM but these high
abundant transcripts constitute the majority of mRNA transcrip-
tome. For example, only 759 (9%) and 760 (9%) gene entries have
TPM above 100, but these transcripts constitute 87% and 89% of
transcriptome respectively in the arsenic-treated and untreated
control groups.
To elucidate the molecular response of zebrafish livers to
arsenic exposure, RNA-SAGE data were subjected to a series of
bioinformatic analyses as outlined in Figure S1. First, 1,444
differentially expressed genes, including 750 up-regulated genes
and 694 down-regulated genes by arsenic treatment (Table S1),
were identified using criteria of fold change $2 and TPM$10 in
either sample (Fig. 1B). The selection of TPM.10 was for analyses
of physiologically significant transcripts as 10 TPM is equivalent to
3.3 transcripts per cell [34,35]. A total of 3,703 and 3,661 genes
had TPM above 10 respectively in the arsenic-treated and
untreated samples and these transcripts constitute about 97% of
mRNA transcriptome (Fig. 1A).
GO analysis of the 1,444 differentially expressed genes, in which
1,211 genes were mapped to identifiers in DAVID Knowledge-
base, showed significant enrichment in several categories (Table 1).
In the Biological Process, the top enrichment terms were oxidation
reduction, translation, homeostatic process, cellular homeostasis,
proteolysis, iron ion transport, cell redox and homeostasis.
Accordingly, in Molecular Function, iron ion binding appeared
to be the top of the list while structural constituent of ribosome and
many other categories apparently related to oxidation reduction
and metabolism were also enriched. In Cellular Component,
mitochondrion appeared at the top of the list, further highlighting
the importance of oxidation reduction in response to arsenic
exposure (Table 1).
Predicted Diseases and Transcription Factors Perturbed
by Arsenic
To further elucidate arsenic-induced transcriptomic changes,
IPA software were used to analyse the differentially expressed
genes to identify associations with disease conditions. Out of the
1,444 differentially expressed genes, 1,025 genes could be mapped
to 921 human homologs and 707 genes were assigned to biological
function analysis in the IPA database. The major and significant
diseases or disorders included Genetic Disorder (462 genes),
Cancer (302 genes), Metabolic Disease (65 genes), Hepatic System
Disease (55 genes), Endocrine System Disorders (28 genes). A
more detailed examination of the sub-functional annotation
showed that Genetic Disorder included immediate hypersensitiv-
ity, hypercholesterolemia and nonalcoholic fatty liver disease.
Many genes were enriched in several cancer categories, including
tumorgenesis, neoplasia, carcinoma, digestive organ tumor and
liver cancer. Metabolic Disease included experimentally-induced
Figure 1. Comparison of transcriptomic profiles between
arsenic-treated and control groups. (A) Distribution of transcript
entries and total transcript counts in both arsenic-treated and control
groups. The percentages of accumulated transcript counts or transcript
entries are plotted over different transcript abundance categories. (B)
Plot of transcript change fold (Y-axis) versus transcript TPM (X-axis) after
arsenic exposure. Both axes are in log2 scale and TPM in the X-axis is
based on the treatment group.
doi:10.1371/journal.pone.0068737.g001
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diabetes, hypercholesterolemia, nonalcoholic fatty liver disease,
etc, while Hepatic System Disease included liver cancer and
cholestasis (Figure 2). Thus, arsenic exposure has a broad effect on
liver function, leading to several metabolic disorders and
potentially cancer, consistent with the findings from previous
reports that liver is a major target of arsenic toxicity and liver
cancer could be induced by chronic exposure to arsenic [7,8,36].
To further analyse molecular relevance to altered biological
process and relevant diseases, IPA upstream factor analysis was
carried out and a network with four hub factors (Nr2f2, Jun, Kras
and ApoE) is presented in Figure 3. The network is apparently
related to oxidative stress (Nr2f2), cancer (Jun, Kras) and
metabolic pathways (ApoE). As displayed in the network, these
upstream factors regulate their downstream factors respectively or
cooperatively. For example, Jun regulated the expression of fth1,
rhob, mdm2, mmp2, ctcf, serpene1, vcam1, cyp7a1, acat1 and other genes.
Of these Jun-regulated genes, fth1, rhob, mdm2 and mmp2 might also
interact with Kras while mmp2, ctcf, serpne1, vcam1 and cyp7a1
interacted with ApoE. The relationship of these factors and their
interaction are further elaborated in Discussion.
Comparative Toxicogenomic Analysis
To define the robust and conserved pathways and genes
regulated by arsenic across species, a comparative toxicogenomic
analysis was conducted between our current study and CTD
database, in which 1,129 genes were curated as chemical-gene
interactions under the term ‘‘sodium arsenate’’
(CTD_C009277_genes). Intersection analysis of this set of genes
and differentially expressed gene set from the current study
showed 84 common arsenic-responsive genes (Table S2). Howev-
er, among the top 239 genes based on fold changes (FC$8) in our
current study (Table S1), only 8 genes (three up-regulated: gsr,
Table 1. Significantly affected gene ontology terms by arsenic exposure.
Category Term Count Enrichment p-Value
Biological GO:0055114,oxidation reduction 78 1.79 3.330E-04
Process GO:0006412,translation 48 2.14 3.759E-04
GO:0042592,homeostatic process 33 2.42 1.384E-03
GO:0019725,cellular homeostasis 25 2.56 7.568E-03
GO:0006508,proteolysis 73 1.54 3.378E-02
GO:0006826,iron ion transport 8 5.79 3.821E-02
GO:0045454,cell redox homeostasis 15 3.10 3.473E-02
Molecular GO:0005506,iron ion binding 48 2.25 8.657E-05
function GO:0003735,structural constituent of ribosome 30 2.49 1.759E-03
GO:0005198,structural molecule activity 51 1.89 2.429E-03
GO:0070011,peptidase activity, acting on L-amino acid peptides 62 1.73 2.944E-03
GO:0008233,peptidase activity 63 1.68 5.511E-03
GO:0008235,metalloexopeptidase activity 10 4.72 1.218E-02
GO:0004866,endopeptidase inhibitor activity 18 2.83 1.112E-02
GO:0008199,ferric iron binding 7 6.89 1.555E-02
GO:0008238,exopeptidase activity 13 3.34 2.094E-02
GO:0030170,pyridoxal phosphate binding 13 3.20 2.872E-02
GO:0070279,vitamin B6 binding 13 3.20 2.872E-02
GO:0004298,threonine-type endopeptidase activity 9 4.43 2.880E-02
GO:0070003,threonine-type peptidase activity 9 4.43 2.880E-02
GO:0030414,peptidase inhibitor activity 18 2.53 2.695E-02
GO:0016769,transferase activity, transferring nitrogenous groups 10 3.81 3.457E-02
GO:0004857,enzyme inhibitor activity 20 2.27 4.203E-02
Cellular GO:0005739,mitochondrion 50 2.25 1.033E-05
component GO:0005840,ribosome 35 2.49 7.856E-05
GO:0005829,cytosol 26 2.58 1.094E-03
GO:0030529,ribonucleoprotein complex 41 1.86 6.125E-03
GO:0000502,proteasome complex 14 3.46 5.464E-03
GO:0044429,mitochondrial part 29 2.10 7.570E-03
GO:0005839,proteasome core complex 9 4.54 1.565E-02
GO:0043232,intracellular non-membrane-bounded organelle 79 1.42 1.907E-02
GO:0043228,non-membrane-bounded organelle 79 1.42 1.907E-02
GO:0005740,mitochondrial envelope 25 2.07 1.949E-02
Note: Count is number of genes involved. Fold Enrichment is (m/n)/(M/N), where N= all genes in zebrafish, M= all genes belonging to a GO term, n=genes from the
differentially expressed gene set, m=genes from the differentially expressed gene set belonging to a GO term.
doi:10.1371/journal.pone.0068737.t001
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klf11, gsto1; five down-regulated: hsd11b2, gsto1, hsd11b2, aldh2,
aqp3, dio2 and krt8) were reported in the CTD dataset (Table S2),
indicating that many of the top arsenic-responsive genes have not
been captured by CTD and hence there is an importance of the
re-examination of arsenic-caused transcriptomic changes using the
RNA sequencing technology.
To elaborate how the arsenic-responsive genes function through
molecular interactions in related diseases, the 1,444 differentially
expressed genes were analysed Gene Set Enricher in the CTD
database. A total of 36 significantly enriched KEGG (Kyoto
Encyclopaedia of Genes and Genomes) pathways were identified
based on 920 genes recognized by Gene Set Enricher. However,
only less than half (17) of these enriched pathways have been
reported in the arsenic CTD dataset (CTD_C009277_pathways)
and 19 pathways were newly identified in the present study,
including the top two most significantly altered pathways,
Metabolic pathways, Proteosome (folding, sorting & degradation)
and many others such as Protein processing in endoplasmic
reticulum, PPAR signaling pathway, Pathways in cancer, MAPK
signaling pathway, Hepatitis C, etc. (Table 2).
Potential Biomarker Genes for Arsenic Exposure
Another important motivation of the current study is to identify
reliable and robust biomarkers suitable for arsenic exposure by
genome-wide search. Here we first tested top up-regulated genes
(55 genes having fold change .8 and TPM.30) for RT-qPCR
validation. Among the top 55 up-regulated genes, 29 of them were
successfully amplified by PCR while the rest 26 genes could not be
analysed either because of insufficient sequences for specific PCR
primers or due to the failure of generating PCR products. Finally
27 genes were confirmed to be up-regulated using the same pooled
RNA sample for RNA-SAGE sequencing, indicating the consis-
tency of the two technical platforms (Table S3). To analyse the
applicability of these genes as biomarkers, we further validated
their changes at individual fish level from another set of fish liver
samples treated with a lower concentration of sodium arsenate
(15 ppm) in order to identify more robustly responsive genes.
Among the nine individual fish tested, 14 out of the 27 genes could
be further validated in at least five individual fish (Figure 4A). 9 out
of the 14 genes showed dosage-dependent response by comparison
their RNA levels between 15 and 20 ppm. Intriguingly, among
these 14 genes, only 4 of them (slc16a9a, acat2, mgstl and slc40a1)
were annotated in the Zebrafish Reference Sequence database. By
manual sequence analyses, we annotated another six transcripts
based on the available cDNA sequences in Genbank (ferritin-like
[NM_001113659], frh3 [NM_001109705], gstl [NM_00102648],
es1l [XM_688586.4], cmbl [NM_001109832] and mgst1
[NM_001002215.1]). However, there are still four unannotated
or potentially novel genes in zebrafish suggesting that there are still
novel arsenic-responsive genes that are being uncovered from the
RNA-seq study.
To further test the putative biomarker genes and their
applicability in other fish species, we performed homolog/ortholog
search of these genes in medaka, which is about 3 million years
divergent from zebrafish in evolution [37]. By gene sequence
alignment and shared synteny analysis, we found medaka
Figure 2. Diseases inferred by IPA based on differentially expressed genes after arsenic exposure. The bar chart shows the number of
arsenic-deregulated genes matched in different disease or disorder categories and only top significant categories (P,0.01) were selected to show.
The same gene may be assigned to more than one categories.
doi:10.1371/journal.pone.0068737.g002
Transcriptomic Analyses of Arsenic Exposure
PLOS ONE | www.plosone.org 5 July 2013 | Volume 8 | Issue 7 | e68737
orthologues/homologues of 9 genes from the 13 validated
zebrafish genes. By RT-qPCR analysis of four individual fish
samples similarly treated with arsenic, four medaka genes were
significantly up-regulated by arsenic in at least three out of four
medaka fish (Fig. 4B). These four genes were frh3 (ferrintin H3),
mgst1 (microsomal glutathione S-transferase-like), cmbl (carboxy-
methylenebutenolidase homolog) and slc40a1 (solute carrier family
40 [iron-regulated transporter], member 1). Interestingly, slc40a1
was also observed to be up-regulated by arsenic exposure in our
previous microarray analysis [22] while the other three genes are
reported to respond arsenic exposure in animals for the first time.
To address the question whether the 14 biomarker genes
identified from zebrafish provide specificity for predicting arsenic
toxicity, we compared the available RNA-SAGE data from other
chemical treatments including 17b-estradiol (E2) [38], 11-keto
testosterone (KT11) [38] and 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) (our unpublished data). We found that only the arsenic
treated sample showed high levels of up-regulation of all of the 14
biomarker genes. Hierarchical clustering indicated that use of the
14 biomarker genes, arsenic-treated samples could be easily
separated from the rest of samples (Figure 4C). Furthermore, using
the four biomarker genes common to both zebrafish and medaka,
the distinction of arsenic-treated samples was even more prom-
inent as the four genes were most down-regulated by other
treatments (Figure 4D). These comparisons indicate the potential
specificity of these biomarker genes for identification of arsenic
toxicity.
Discussion
Biological Processes Perturbed by Arsenic Exposure
The present study represents the first comprehensive analysis of
genome-wide response to arsenic exposure in an in vivo biological
model. Arsenic exposure caused a change of the expression of a
Figure 3. Key upstream regulator networks modulated by arsenic exposure. The upstream network was generated by IPA and the
networks indicate predicted upstream regulators and their downstream target genes presented in the differentially expressed gene set. Up-regulated
genes are in red and down-regulated in green. Solid arrow lines represent direct interaction while dotted lines indirect intereaction.
doi:10.1371/journal.pone.0068737.g003
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large number of genes and these differentially expressed genes
were inferred to be mainly involved oxidation reduction,
translation, homeostatic process, iron ion binding and transport
by GO analysis (see Table 1 for complete list).
The oxidation reduction process was up-regulated, suggesting
potential oxidative stress induced by arsenic exposure in the
zebrafish liver, which is consistent with previously reports that
oxidative stress is an important initiating factor in the pathogenesis
of arsenic-induced liver injury [39,40]. Furthermore, oxidative
stress would subsequently alter the expression of genes involved in
cellular homeostasis [41] and increased production of oxidizing
species leading to glutathione depletion [42]. Consistent with our
data, it has been reported from arsenic-fed mice that there is a
decreased level of hepatic glutathione as well as decreased enzyme
activities of glucose-6-phosphate dehydrogenase (G6pd) and
glutathione peroxidase (Gpx) [43]. In contrast, cells resisting to
arsenic toxicity in mammals correlate with higher levels of
glutathione and glutathione-related enzymes including glutathione
reductase (Gsr), glutathione S-transferase (Gst) and glutamate
cysteine ligase (Gcl) [44]. Similarly, our RNA-SAGE data
indicated that the mRNA level for gpx8 (glutathione peroxidase
8) were decreased while genes encoding glutathione related
enzymes including gsr, gstm3 (glutathione S-transferase mu 3),
gsto1 (glutathione S-transferase omega 1), gstt1b (glutathione S-
transferase theta 1 glutathione S-transferase theta 1b), herpud1
(homocysteine-inducible, endoplasmic reticulum stress-inducible,
Table 2. Enriched KEGG pathways identified by Gene Set Enricher of CTD.
Pathways Pathway ID P-value Gene counts
*Metabolic pathways KEGG:01100 3.99E-49 142
*Proteasome (folding, sorting & degradation) KEGG:03050 1.58E-11 16
Glycine, serine and threonine metabolism KEGG:00260 1.05E-08 12
Glycolysis/gluconeogenesis KEGG:00010 1.10E-06 14
*Arginine & proline metabolism KEGG:00330 1.41E-06 13
*Glutathione Metabolism KEGG:00480 4.05E-06 12
*Protein processing in endoplasmic reticulum KEGG:04141 4.20E-06 21
Tryptophan metabolism KEGG:00380 7.15E-06 11
*PPAR signaling pathways KEGG:03320 2.02E-05 13
Oxidative phosphorylation KEGG:00190 2.79E-05 17
Ribosome KEGG:03010 7.19E-05 14
*Pathways in cancer KEGG:05200 9.58E-05 27
*MAPK signaling pathway KEGG:04010 1.77E-04 24
*Hepatitis C KEGG:05160 2.52E-04 16
Purine metabolism KEGG:00230 3.45E-04 18
Bladder cancer KEGG:05219 3.68E-04 9
Proximal tubule bicarbonate reclamation KEGG:04964 4.41E-04 7
Peroxisome KEGG:04146 4.95E-04 12
Propanoate metabolism KEGG:00640 6.76E-04 8
Fat digestion and absorption KEGG:04975 0.00143 9
*Ubiquitin mediated proteolysis KEGG:04120 0.00162 15
Antigen processing and presentation KEGG:04612 0.00192 11
*Cardiac muscle contraction KEGG:04260 0.00218 11
*Cell cycle KEGG:04110 0.00261 14
*Mineral absorption KEGG:04978 0.00281 9
*Endometrial cancer KEGG:05213 0.0033 9
Parkinson’s disease KEGG:05012 0.00341 14
*Huntington KEGG:05016 0.00381 17
Complement and coagulation cascades KEGG:04610 0.00447 10
*Leukocyte transendothelial migration KEGG:04670 0.0046 13
*Carbohydrate digestion and absorption KEGG:04973 0.00522 8
Pyrimidine metabolism KEGG:00240 0.00549 12
TCA cycle KEGG:00020 0.00609 7
Pyruvate metabolism KEGG:00620 0.0062 8
*Prostate cancer KEGG:05215 0.00856 11
*Insulin signaling KEGG:04910 0.00914 14
Note: Pathways indicated with asterisks are newly identified in the present study.
doi:10.1371/journal.pone.0068737.t002
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ubiquitin-like domain member 1), mgst1 (microsomal glutathione
S-transferase 1) and mgst3 (microsomal glutathione S-transferase 3)
were up-regulated (Table S1, Table 2). In addition, several
important cellular antioxidants were also deregulated, including
up-regulated prdx2 (peroxiredoxin 2), mt2 (Metallothionein-2) and
gls2 (glutaminase 2), and down-regulated cat (catalase) (Table S1).
It is also well documented that iron or iron containing molecules
interact with the oxidizing agents such as H2O2 and therefore play
an important role in reducing cellular oxidative stress [45]. It has
also been shown that intra-lysosomal iron chelation is able to
reduce H2O2-induced DNA damage and apoptosis in cultured
cells [46–48]. Consistent with this, one of the most significant
molecular function identified from our transcriptomic analysis is
iron ion binding. Iron is an essential constituent of living cells and
organisms as it is involved in fundamental functions, including
oxygen transport, DNA biosynthesis, transfer of electrons in the
respiratory chain and xenobiotic metabolism [49]. Iron deficiency
leads to anemia due to the depletion of iron store and thus
insufficient haemoglobin in the blood. However, iron is also
potentially toxic and excess iron promotes oxidative stress and
tissue damage, resulting in complications such as liver fibrosis,
hepatocellular carcinoma or diabetes [50,51]. Therefore, it is
understandable from our transcriptomic data analysis that arsenic
exposure was associated with many genetic disorders, metabolic
Figure 4. Preliminary identification of potential biomarker genes for arsenic exposure. Selected up-regulated genes by arsenic exposure
were examined by RT-qPCR in individual zebrafish (A) and medaka (B) after treatment with arsenic. (A), Fold changes (log2 ratio) of 14 up-regulated
genes measured by RT-qPCR. S1-S9, 9 individual zebrafish treated with 15 ppm sodium; 15 ppm, average of the 9 individual fish; 20 ppm, RT-qPCR
measurement from the pooled RNA sample used for RNA-SAGE sequencing; SAGE, RNA-SAGE data for comparison (Log2 fold change). The 9 genes
displayed dosage-dependent effect between 15 ppm and 20 ppm are indicated with asterisks. Zebrafish gene symbols and names are shown based
on NCBI and underlined genes are annotated manually. (B), Average of fold changes (log2 ratio) of four validated medaka genes in 4 individual
medaka fish. (C) Comparison of the expression of arsenic biomarker genes in other chemical treatments by hierarchical clustering heatmap. RNA-
SAGE data from the current study (Arsenic) were compared with hepatic RNA-SAGE data from zebrafish treated with 5 mg/L 17b-estradiol (E2), 5 mg/L
11-keto testosterone (KT11) or 10 nM 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). The left clustering is based on the 14 genes identified from
zebrafish and the right based on the four genes from both zebrafish and medaka.
doi:10.1371/journal.pone.0068737.g004
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diseases, hepatic system diseases and even cancers through
disruption of metabolic pathways, immune system, PPARa
signaling pathway, and glutathione metabolism.
The hallmarks of iron deficiency and excess are determined by
several critical proteins involved in iron binding, transport and
recycle [52,53]. In our study, a number of genes involved in iron
binding and transport, such as slc40a1 (solute carrier family 40
[iron-regulated transporter] member 1, also known as ferroportin
1), fth1 (ferritin, heavy polypeptide 1) and frh3 (ferrintin H3), were
up-regulated by arsenic exposure, implying that the iron
homeostasis of liver was perturbed. Moreover, both slc40a1 and
fth1 have been previously reported to be associated with arsenate
toxicity [22,54]. Slc40a1 encodes a cellular iron exporter to
transport iron from inside a cell and is mainly expressed in
macrophages, enterocytes, and hepatocytes [55–57]. Fth1 encodes
a heavy subunit of ferritin, a globular protein complex consisting
of 24 subunits, which is the primary intracellular iron-storage
protein in both prokaryotes and eukaryotes for keeping iron in a
soluble and non-toxic form and thus acts as a buffer against iron
deficiency and overloading. Frh3 encodes an uncharacterized
protein of 175 amino acid (NP_001103175) that contains a
ferritin-like domain (NCBI domain ID: pfam00210) as it displays
high identity (96%) with catfish ferritin H [58] and mammalian
Ferritin [59]. The concentration of Ferritin increases in response
to stresses including anoxia, pathogenesis and carcinogenesis [60].
For instance, it has also been reported that Ferritin binds and
activates p53 under oxidative stress [61] and the overexpression of
H-ferritin (Ferritin heavy subunit) promotes radiation-induced
leukemia/lymphoma in mice [62]. Interestingly, both frh3 and
slc40a1 were identified to be up-regulated by arsenic in both
zebrafish and medaka in the present study (Figure 4).
Iron is mainly stored in macrophages of the reticulo-endothelial
system and in hepatocytes [63,64]. It has been proposed that a
nuclear-encoded mitochondrial ferritin isoform is very likely
involved in the storage of excess iron within the mitochondria
[65] which, as a site for iron utilization and ROS (reactive oxygen
species) production, are particularly vulnerable to oxidative stress.
Iron may be mobilized from the ferritin complex to cytoplasm
following localized protein unfolding [66] or degradation in
lysosomes [67]. Ferritin may also undergo degradation by the
proteasome, following iron depletion or oxidation [68]. Therefore,
the differentially expressed genes of this study were significantly
enriched as components of mitochondrion, ribosome and protea-
some complex.
Networks and Diseases Relevant to Arsenic Exposure
As reported from experimental and clinic investigations,
inorganic arsenic can cause a variety of cancer [7,8], diabetes
[9] and other diseases. However, it remains largely unclear about
the molecular events behind the pathogenesis of arsenic exposure.
Our transcriptomic analysis may provide molecular insights
associating the differentially expressed genes to cancers and
metabolic diseases (Figure 2). Further analysis of upstream
regulators and network revealed four hub factors, Nr2f2, Jun,
Kras and ApoE (Figure 3). Moreover, many transcription factors,
such as Prox1, Nr1d1, Rxrg, Hlf, Nr0b2, Foxm1, Nfn1a, Jun,
Junb, Fox3, Etv5, Sqtm1, and NF-kB1b were differentially
regulated by arsenic exposure in our data, consistent with reports
in mammalian cells, where the AP-1 complex, NF-kB, and the
MTF-1 (metal-responsive transcription factor 1) could be activated
by arsenic [69–72].
As illustrated in Figure 3, Jun may regulate the expression of
more than 30 genes. Among these, fth1, rhob, mdm2 and mmp2 are
also regulated by Kras, another prominent oncoprotein [73–75].
Here, Kras may directly or indirectly regulate the activity of abcc4,
anpep, b2m, cd74, cdh2, eef1A1, fth1, gadd45A, hexa, id1, igfbp2, ip6k2,
mdm2, mmp2, nfkbib, rab20, rhob, and sqstm1. Most of these genes
have been well documented for tumorgenesis and immune
response. For example, Nfkbib (NF-kappa-B inhibitor beta)
functions to inhibit the NF-kB transcription factor [76]. Dereg-
ulation of NF-kB has been linked to cancer, inflammatory and
autoimmune diseases [77–79]. RhoA (Ras homolog gene family,
member) is a small GTPase protein known to be involved in the
regulation of cell division [80]. Rab20, another member of RAS
oncogene family, is also up-regulated by Kras. Mdm2 (murine
double minute, oncogene) is an important negative regulator of the
p53 tumor suppressor [81,82] and Mdm2 overexpression, in
cooperation with oncogenic Ras, promotes transformation of
primary rodent fibroblasts and tumorigenesis in nude mice [83]. In
addition, Egfr (epidermal growth factor receptor) [84], Gadd45A
(growth arrest and DNA-damage-inducible protein) [85] and Id1
(inhibitor of differentiation) [86,87] are well known to function in
cancer pathways. Interestingly we observed in this study that Jun
and Kras appeared to directly up-regulate fth1, which acts as a
buffer against iron deficiency and overloading [88]. This further
explains the relationship between iron homeostasis and tumorgen-
esis, and illustrates the molecular mechanisms behind the previous
reports that the concentration of Ferritin increases in response to
stresses including anoxia [60], pathogenesis and carcinogenesis
[89].
ApoE is essential for catabolism of triglyceride-rich lipoprotein
constituents [90]. Here, the significant down-regulation of ApoE
possibly reduced the expression of apoa1, cyp7a1, calr, acat1, cat, cetp,
fkbp4, fkbp5, mmp2 and hmox1, and increased expression of ctss, ctsl2,
gpx4, sdc4 and apca1. Some of these genes have been well
documented and related to metabolism, especial to lipid metab-
olism. For example, Apoa is secreted into blood circulation on the
surface of newly synthesized chylomicron particles and modulates
the efficiency of enterocyte and hepatic transcellular lipid transport
in vitro [91]. The altered expression of cat (catalase) is associated
with oxidative DNA damage and subsequent cancer susceptibility
[92,93]. Cetp (Cholesteryl ester transfer protein), also called
plasma lipid transfer protein [94,95] and Abca1 (ATP-binding
cassette transporter sub-family) are major regulators of cellular
cholesterol and phospholipid homeostasis. Abca1functions as a
cholesterol efflux pump in the cellular lipid removal pathway [96].
It also mediates the transport of lipids between Golgi and cell
membrane. Since Abca1 is needed throughout the body, it is
present highly in tissues involved in the turnover of lipids such as
the liver and adipose tissue [96]. Overexpression of ABCA1 has
been reported to induce resistance to curcumin, a dietary
polyphenolic antioxidant with an anti-inflammatory role [97].
GPX4 (Glutathione peroxidase 4) in humans protects cells against
membrane lipid peroxidation [98]. Therefore, through the effect
of ApoE and its downstream genes, arsenic modulated the lipid
metabolism in zebrafish liver. It is also interesting to note that the
expression of jun might also be affected by ApoE, further
highlighting the increasingly recognized relationship of carcino-
genesis and metabolic disorders [90].
Nr2f2 (nuclear receptor subfamily 2, group F, member 2) is a
member of the steroid thyroid hormone superfamily of nuclear
receptors [99] and it appeared to be involved in the regulation of
many different genes including aldh2, nr1h4, apoa1, apoa4, cyp7a1,
lpl, pck1, cyp11b2 and rbp2 (Figure 3). Most of these genes are
related to oxidative stress and drug metabolism. For example,
aldh2 encodes a member of the aldehyde dehydrogenase family
and it is the second enzyme of the major oxidative pathway of
alcohol metabolism [100]. Nr1h4 (nuclear receptor subfamily 1,
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group H, member 4) is a nuclear receptor and regulates the
expression of genes involved in bile acid synthesis and transport
[101]. Pck1, Phosphoenolpyruvate carboxykinase 1 (soluble), is a
main control point for the regulation of gluconeogenesis [102].
Cyp11b2 (cytochrome P450, family 11, subfamily B, polypeptide
2) and Cyp7a1 (cytochrome P450, family 7, subfamily A,
polypeptide 1) belong to the cytochrome P450 protein family
and these monooxygenases catalyze many reactions involved in
drug metabolism and synthesis of cholesterol, steroids and other
lipids, that are related to cellular oxidative stress [103,104].
In summary, our study indicates that arsenic could evoke a
series of molecular events involved in oxidative stress, iron
homeostasis, lipid metabolism disorder and carcinogenesis. The
top significant molecular functions of differentially expressed genes
included iron ion binding, structural constituent of ribosome and
several types of peptidase activity (Table 1) which are related to
oxidative stress, iron homeostasis and metabolism processes.
However, whether these effects are mainly associated with arsenic
or some of them may also be commonly shared by other metal
toxicants will be an interesting question for future investigation
using the RNA-seq based transcriptomic approach.
Supporting Information
Figure S1 Flowchart of the study. Main steps and analyses
are represented in each box in chronical order. Data generated
from these analyses are shown in figures and tables as indicated in
each box.
(PDF)
Table S1 1,444 differentially expressed genes by arse-
nic treatment (Fold change .2, TPM.10).
(XLSX)
Table S2 84 arsenic-responsive genes common to this
study and to CTD.
(XLS)
Table S3 Up-regulated genes validated by qPCR using
the same RNA sample for RNA sequencing.
(DOCX)
Author Contributions
Conceived and designed the experiments: HX SHL ZG. Performed the
experiments: HX YS. Analyzed the data: HX SHL ZG. Contributed
reagents/materials/analysis tools: HX SHL ZG. Wrote the paper: HX
ZG.
References
1. Fendorf S, Michael HA, van Geen A (2010) Spatial and temporal variations of
groundwater arsenic in South and Southeast Asia. Science 328: 1123–1127.
2. Flora SJ, Bhadauria S, Pant SC, Dhaked RK (2005) Arsenic induced blood and
brain oxidative stress and its response to some thiol chelators in rats. Life Sci
77: 2324–2337.
3. Mandal BK, Suzuki KT (2002) Arsenic round the world: a review. Talanta 58:
201–235.
4. Cohen SM, Ohnishi T, Arnold LL, Le XC (2007) Arsenic-induced bladder
cancer in an animal model. Toxicol Appl Pharmacol 222: 258–263.
5. Aposhian HV, Zheng B, Aposhian MM, Le XC, Cebrian ME, et al. (2000)
DMPS-arsenic challenge test. II. Modulation of arsenic species, including
monomethylarsonous acid (MMA(III)), excreted in human urine. Toxicol Appl
Pharmacol 165: 74–83.
6. Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, et al. (2000)
Occurrence of monomethylarsonous acid in urine of humans exposed to
inorganic arsenic. Chem Res Toxicol 13: 693–697.
7. IARC (2004) Some drinking-water disinfectants and contaminants, including
arsenic. Monographs on chloramine, chloral and chloral hydrate, dichlor-
oacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-
2(5H)-furanone. IARC Monogr Eval Carcinog Risks Hum 84: 269–477.
8. Smith AH, Steinmaus CM (2009) Health effects of arsenic and chromium in
drinking water: recent human findings. Annu Rev Public Health 30: 107–122.
9. Diaz-Villasenor A, Burns AL, Hiriart M, Cebrian ME, Ostrosky-Wegman P
(2007) Arsenic-induced alteration in the expression of genes related to type 2
diabetes mellitus. Toxicol Appl Pharmacol 225: 123–133.
10. Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, et al. (1999)
Arsenic: health effects, mechanisms of actions, and research issues. Environ
Health Perspect 107: 593–597.
11. de Castro MR, Lima JV, de Freitas DP, Valente Rde S, Dummer NS, et al.
(2009) Behavioral and neurotoxic effects of arsenic exposure in zebrafish (Danio
rerio, Teleostei: Cyprinidae). Comp Biochem Physiol C Toxicol Pharmacol
150: 337–342.
12. De Vizcaya-Ruiz A, Barbier O, Ruiz-Ramos R, Cebrian ME (2009)
Biomarkers of oxidative stress and damage in human populations exposed to
arsenic. Mutat Res 674: 85–92.
13. Huang CF, Chen YW, Yang CY, Tsai KS, Yang RS, et al. (2011) Arsenic and
diabetes: current perspectives. Kaohsiung J Med Sci 27: 402–410.
14. Ghosh P, Banerjee M, Giri AK, Ray K (2008) Toxicogenomics of arsenic:
classical ideas and recent advances. Mutat Res 659: 293–301.
15. Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, et al. (2011) Arsenic:
toxicity, oxidative stress and human disease. J Appl Toxicol 31: 95–107.
16. Postlethwait JH, Yan YL, Gates MA, Horne S, Amores A, et al. (1998)
Vertebrate genome evolution and the zebrafish gene map. Nat Genet 18: 345–
349.
17. Woods IG, Kelly PD, Chu F, Ngo-Hazelett P, Yan YL, et al. (2000) A
comparative map of the zebrafish genome. Genome Res 10: 1903–1914.
18. Woods IG, Wilson C, Friedlander B, Chang P, Reyes DK, et al. (2005) The
zebrafish gene map defines ancestral vertebrate chromosomes. Genome Res
15: 1307–1314.
19. Catchen JM, Braasch I, Postlethwait JH (2011) Conserved synteny and the
zebrafish genome. Methods Cell Biol 104: 259–285.
20. Pichler FB, Laurenson S, Williams LC, Dodd A, Copp BR, et al. (2003)
Chemical discovery and global gene expression analysis in zebrafish. Nat
Biotechnol 21: 879–883.
21. Lam SH, Mathavan S, Tong Y, Li H, Karuturi RK, et al. (2008) Zebrafish
whole-adult-organism chemogenomics for large-scale predictive and discovery
chemical biology. PLoS Genet 4: e1000121.
22. Lam SH, Winata CL, Tong Y, Korzh S, Lim WS, et al. (2006) Transcriptome
kinetics of arsenic-induced adaptive response in zebrafish liver. Physiol
Genomics 27: 351–361.
23. Hegedus Z, Zakrzewska A, Agoston VC, Ordas A, Racz P, et al. (2009) Deep
sequencing of the zebrafish transcriptome response to mycobacterium
infection. Mol Immunol 46: 2918–2930.
24. Ordas A, Hegedus Z, Henkel CV, Stockhammer OW, Butler D, et al. (2011)
Deep sequencing of the innate immune transcriptomic response of zebrafish
embryos to Salmonella infection. Fish Shellfish Immunol 31: 716–724.
25. Stockhammer OW, Rauwerda H, Wittink FR, Breit TM, Meijer AH, et al.
(2010) Transcriptome analysis of Traf6 function in the innate immune response
of zebrafish embryos. Mol Immunol 48: 179–190.
26. Guo L, Lobenhofer EK, Wang C, Shippy R, Harris SC, et al. (2006) Rat
toxicogenomic study reveals analytical consistency across microarray platforms.
Nat Biotechnol 24: 1162–1169.
27. Shi L, Jones WD, Jensen RV, Harris SC, Perkins RG, et al. (2008) The balance
of reproducibility, sensitivity, and specificity of lists of differentially expressed
genes in microarray studies. BMC Bioinformatics 9 Suppl 9: S10.
28. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:
44–57.
29. Davis AP, King BL, Mockus S, Murphy CG, Saraceni-Richards C, et al. (2011)
The Comparative Toxicogenomics Database: update 2011. Nucleic Acids Res
39: D1067–1072.
30. Davis AP, Murphy CG, Johnson R, Lay JM, Lennon-Hopkins K, et al. (2013)
The Comparative Toxicogenomics Database: update 2013. Nucleic Acids Res
41: D1104–1114.
31. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric
averaging of multiple internal control genes. Genome Biol 3: RE-
SEARCH0034.
32. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007)
qBase relative quantification framework and software for management and
automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
33. McCurley AT, Callard GV (2008) Characterization of housekeeping genes in
zebrafish: male-female differences and effects of tissue type, developmental
stage and chemical treatment. BMC Mol Biol 9: 102.
34. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping
and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5:
621–628.
Transcriptomic Analyses of Arsenic Exposure
PLOS ONE | www.plosone.org 10 July 2013 | Volume 8 | Issue 7 | e68737
35. Zheng W, Wang Z, Collins JE, Andrews RM, Stemple D, et al. (2011)
Comparative transcriptome analyses indicate molecular homology of zebrafish
swimbladder and mammalian lung. PLoS One 6: e24019.
36. Liu J, Waalkes MP (2008) Liver is a target of arsenic carcinogenesis. Toxicol Sci
105: 24–32.
37. Muller F (2005) Comparative aspects of alternative laboratory fish models.
Zebrafish 2: 47–54.
38. Zheng W, Xu H, Lam SH, Luo H, Karuturi RK, et al. (2013) Transcriptomic
analyses of sexual dimorphism of the zebrafish liver and the effect of sex
hormones. PLoS One 8: e53562.
39. Shi H, Shi X, Liu KJ (2004) Oxidative mechanism of arsenic toxicity and
carcinogenesis. Mol Cell Biochem 255: 67–78.
40. Hei TK, Filipic M (2004) Role of oxidative damage in the genotoxicity of
arsenic. Free Radic Biol Med 37: 574–581.
41. Dalton TP, Shertzer HG, Puga A (1999) Regulation of gene expression by
reactive oxygen. Annu Rev Pharmacol Toxicol 39: 67–101.
42. Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed
through the redox state of the glutathione disulfide/glutathione couple. Free
Radic Biol Med 30: 1191–1212.
43. Maiti S, Chatterjee AK (2001) Effects on levels of glutathione and some related
enzymes in tissues after an acute arsenic exposure in rats and their relationship
to dietary protein deficiency. Arch Toxicol 75: 531–537.
44. Schuliga M, Chouchane S, Snow ET (2002) Upregulation of glutathione-
related genes and enzyme activities in cultured human cells by sublethal
concentrations of inorganic arsenic. Toxicol Sci 70: 183–192.
45. Merkofer M, Kissner R, Hider RC, Brunk UT, Koppenol WH (2006) Fenton
chemistry and iron chelation under physiologically relevant conditions:
Electrochemistry and kinetics. Chem Res Toxicol 19: 1263–1269.
46. Doulias PT, Christoforidis S, Brunk UT, Galaris D (2003) Endosomal and
lysosomal effects of desferrioxamine: protection of HeLa cells from hydrogen
peroxide-induced DNA damage and induction of cell-cycle arrest. Free Radic
Biol Med 35: 719–728.
47. Baird SK, Kurz T, Brunk UT (2006) Metallothionein protects against oxidative
stress-induced lysosomal destabilization. Biochem J 394: 275–283.
48. Tenopoulou M, Doulias PT, Barbouti A, Brunk U, Galaris D (2005) Role of
compartmentalized redox-active iron in hydrogen peroxide-induced DNA
damage and apoptosis. Biochem J 387: 703–710.
49. Habbersett RC, Jett JH (2004) An analytical system based on a compact flow
cytometer for DNA fragment sizing and single-molecule detection. Cytometry A
60: 125–134.
50. Adams PC (2004) Haemochromatosis: find them or forget about them?
Eur J Gastroenterol Hepatol 16: 857–858.
51. Papanikolaou G, Pantopoulos K (2005) Iron metabolism and toxicity. Toxicol
Appl Pharmacol 202: 199–211.
52. Brittenham GM (2005) Iron balance in the red blood cell donor. Dev Biol
(Basel) 120: 77–82.
53. Camaschella C, Silvestri L (2011) Molecular mechanisms regulating hepcidin
revealed by hepcidin disorders. ScientificWorldJournal 11: 1357–1366.
54. Rea MA, Gregg JP, Qin Q, Phillips MA, Rice RH (2003) Global alteration of
gene expression in human keratinocytes by inorganic arsenic. Carcinogenesis
24: 747–756.
55. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, et al. (2000) Positional
cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter.
Nature 403: 776–781.
56. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, et al. (2000) A novel
duodenal iron-regulated transporter, IREG1, implicated in the basolateral
transfer of iron to the circulation. Mol Cell 5: 299–309.
57. Abboud S, Haile DJ (2000) A novel mammalian iron-regulated protein
involved in intracellular iron metabolism. J Biol Chem 275: 19906–19912.
58. Liu H, Takano T, Peatman E, Abernathy J, Wang S, et al. (2010) Molecular
characterization and gene expression of the channel catfish ferritin H subunit
after bacterial infection and iron treatment. J Exp Zool A Ecol Genet Physiol
313: 359–368.
59. Andrews SC, Arosio P, Bottke W, Briat JF, von Darl M, et al. (1992) Structure,
function, and evolution of ferritins. J Inorg Biochem 47: 161–174.
60. Larade K, Storey KB (2006) Analysis of signal transduction pathways during
anoxia exposure in a marine snail: a role for p38 MAP kinase and downstream
signaling cascades. Comp Biochem Physiol B Biochem Mol Biol 143: 85–91.
61. Lee JH, Jang H, Cho EJ, Youn HD (2009) Ferritin binds and activates p53
under oxidative stress. Biochem Biophys Res Commun 389: 399–404.
62. Hasegawa S, Morokoshi Y, Kanda H, Tsukamoto S, Zheng J, et al. (2012) H-
ferritin overexpression promotes radiation-induced leukemia/lymphoma in
mice. Carcinogenesis 33: 2269–2275.
63. Ganz T (2006) Hepcidin and its role in regulating systemic iron metabolism.
Hematology Am Soc Hematol Educ Program: 29–35, 507.
64. Muckenthaler MU, Galy B, Hentze MW (2008) Systemic iron homeostasis and
the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory
network. Annu Rev Nutr 28: 197–213.
65. Levi S, Arosio P (2004) Mitochondrial ferritin. Int J Biochem Cell Biol 36:
1887–1889.
66. Takagi H, Shi D, Ha Y, Allewell NM, Theil EC (1998) Localized unfolding at
the junction of three ferritin subunits. A mechanism for iron release? J Biol
Chem 273: 18685–18688.
67. Radisky DC, Kaplan J (1998) Iron in cytosolic ferritin can be recycled through
lysosomal degradation in human fibroblasts. Biochem J 336 (Pt 1): 201–205.
68. De Domenico I, Vaughn MB, Li L, Bagley D, Musci G, et al. (2006)
Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation
by the proteasome. EMBO J 25: 5396–5404.
69. Barchowsky A, Roussel RR, Klei LR, James PE, Ganju N, et al. (1999) Low
levels of arsenic trioxide stimulate proliferative signals in primary vascular cells
without activating stress effector pathways. Toxicol Appl Pharmacol 159: 65–
75.
70. Tully DB, Collins BJ, Overstreet JD, Smith CS, Dinse GE, et al. (2000) Effects
of arsenic, cadmium, chromium, and lead on gene expression regulated by a
battery of 13 different promoters in recombinant HepG2 cells. Toxicol Appl
Pharmacol 168: 79–90.
71. Cavigelli M, Li WW, Lin A, Su B, Yoshioka K, et al. (1996) The tumor
promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase.
EMBO J 15: 6269–6279.
72. Kaltreider RC, Pesce CA, Ihnat MA, Lariviere JP, Hamilton JW (1999)
Differential effects of arsenic(III) and chromium(VI) on nuclear transcription
factor binding. Mol Carcinog 25: 219–229.
73. McGrath JP, Capon DJ, Smith DH, Chen EY, Seeburg PH, et al. (1983)
Structure and organization of the human Ki-ras proto-oncogene and a related
processed pseudogene. Nature 304: 501–506.
74. Popescu NC, Amsbaugh SC, DiPaolo JA, Tronick SR, Aaronson SA, et al.
(1985) Chromosomal localization of three human ras genes by in situ molecular
hybridization. Somat Cell Mol Genet 11: 149–155.
75. Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Lam SH, et al. (2011) A
high level of liver-specific expression of oncogenic Kras(V12) drives robust liver
tumorigenesis in transgenic zebrafish. Dis Model Mech 4: 801–813.
76. Jacobs MD, Harrison SC (1998) Structure of an IkappaBalpha/NF-kappaB
complex. Cell 95: 749–758.
77. Gilmore TD (2006) Introduction to NF-kappaB: players, pathways, perspec-
tives. Oncogene 25: 6680–6684.
78. Doyle SL, O’Neill LA (2006) Toll-like receptors: from the discovery of
NFkappaB to new insights into transcriptional regulations in innate immunity.
Biochem Pharmacol 72: 1102–1113.
79. Hayden MS, West AP, Ghosh S (2006) NF-kappaB and the immune response.
Oncogene 25: 6758–6780.
80. Cai S, Exton JH (2001) Determination of interaction sites of phospholipase D1
for RhoA. Biochem J 355: 779–785.
81. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid
degradation of p53. Nature 387: 296–299.
82. Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, et al. (1998) p300/
MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell
2: 405–415.
83. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, et al. (2004) In vivo
activation of the p53 pathway by small-molecule antagonists of MDM2.
Science 303: 844–848.
84. Zhang YW, Wang R, Liu Q, Zhang H, Liao FF, et al. (2007) Presenilin/
gamma-secretase-dependent processing of beta-amyloid precursor protein
regulates EGF receptor expression. Proc Natl Acad Sci U S A 104: 10613–
10618.
85. Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW, et al. (1993)
Analysis of the mammalian gadd45 gene and its response to DNA damage.
J Biol Chem 268: 24385–24393.
86. Chan AS, Jensen KK, Skokos D, Doty S, Lederman HK, et al. (2009) Id1
represses osteoclast-dependent transcription and affects bone formation and
hematopoiesis. PLoS One 4: e7955.
87. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, et al. (2001) Impaired
recruitment of bone-marrow-derived endothelial and hematopoietic precursor
cells blocks tumor angiogenesis and growth. Nat Med 7: 1194–1201.
88. Arosio P, Ingrassia R, Cavadini P (2009) Ferritins: a family of molecules for
iron storage, antioxidation and more. Biochim Biophys Acta 1790: 589–599.
89. Jiang XP, Elliott RL, Head JF (2010) Manipulation of iron transporter genes
results in the suppression of human and mouse mammary adenocarcinomas.
Anticancer Res 30: 759–765.
90. Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid
transport protein. Annu Rev Genomics Hum Genet 1: 507–537.
91. Deeg MA, Bowen RF, Williams MD, Olson LK, Kirk EA, et al. (2001)
Increased expression of GPI-specific phospholipase D in mouse models of type
1 diabetes. Am J Physiol Endocrinol Metab 281: E147–154.
92. Kosa Z, Nagy T, Nagy E, Fazakas F, Goth L (2012) Decreased blood catalase
activity is not related to specific beta-thalassemia mutations in Hungary.
Int J Lab Hematol 34: 172–178.
93. Chang D, Hu ZL, Zhang L, Zhao YS, Meng QH, et al. (2012) Association of
catalase genotype with oxidative stress in the predication of colorectal cancer:
modification by epidemiological factors. Biomed Environ Sci 25: 156–162.
94. Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, et al.
(2003) Cholesteryl ester transfer protein: a novel target for raising HDL and
inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 23: 160–167.
95. Darabi M, Abolfathi AA, Noori M, Kazemi A, Ostadrahimi A, et al. (2009)
Cholesteryl ester transfer protein I405V polymorphism influences apolipopro-
tein A-I response to a change in dietary fatty acid composition. Horm Metab
Res 41: 554–558.
Transcriptomic Analyses of Arsenic Exposure
PLOS ONE | www.plosone.org 11 July 2013 | Volume 8 | Issue 7 | e68737
96. Schmitz G, Langmann T (2001) Structure, function and regulation of the
ABC1 gene product. Curr Opin Lipidol 12: 129–140.
97. Bachmeier BE, Iancu CM, Killian PH, Kronski E, Mirisola V, et al. (2009)
Overexpression of the ATP binding cassette gene ABCA1 determines
resistance to Curcumin in M14 melanoma cells. Mol Cancer 8: 129.
98. Esworthy RS, Doan K, Doroshow JH, Chu FF (1994) Cloning and sequencing
of the cDNA encoding a human testis phospholipid hydroperoxide glutathione
peroxidase. Gene 144: 317–318.
99. Qiu Y, Krishnan V, Zeng Z, Gilbert DJ, Copeland NG, et al. (1995) Isolation,
characterization, and chromosomal localization of mouse and human COUP-
TF I and II genes. Genomics 29: 240–246.
100. Crabb DW, Matsumoto M, Chang D, You M (2004) Overview of the role of
alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the
genesis of alcohol-related pathology. Proc Nutr Soc 63: 49–63.
101. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, et al. (1995) Identification
of a nuclear receptor that is activated by farnesol metabolites. Cell 81: 687–693.
102. Beale EG, Hammer RE, Antoine B, Forest C (2004) Disregulated
glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends
Endocrinol Metab 15: 129–135.
103. Guengerich FP (2008) Cytochrome p450 and chemical toxicology. Chem Res
Toxicol 21: 70–83.
104. Parr MK, Zollner A, Fussholler G, Opfermann G, Schlorer N, et al. (2012)
Unexpected contribution of cytochrome P450 enzymes CYP11B2 and CYP21,
as well as CYP3A4 in xenobiotic androgen elimination - insights from
metandienone metabolism. Toxicol Lett 213: 381–391.
Transcriptomic Analyses of Arsenic Exposure
PLOS ONE | www.plosone.org 12 July 2013 | Volume 8 | Issue 7 | e68737
